Moreover, chronic intermittent hypoxia, the most characteristic pathophysiological change of obstructive sleep apnea syndrome, has been reported to induce cardiac hypertrophy in animal models, and the beneficial cardiac effects are produced by inhibition of the TLR4/MyD88/NF-κB pathway (73). Here, TLR4 is linked to cardiac hypertrophy.